ArticleAdvanced healthcare materials2025
Predicting Mechanosensitive T Cell Expansion from Cell Spreading.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Leveraging Microphysiological Systems to Facilitate Neutrophil-Based Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Targeting delayed healing tissues: immune reprogramming of adaptive immune cells by biomaterials.Regenerative biomaterials · 2026Review
- AI-driven biomaterial design: an intelligent closed loop from reverse design to biological response.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Variability in T cell performance presents a major challenge to adoptive cellular immunotherapy (ACT). This includes expansion of a small starting population into therapeutically effective numbers, which can fail due to differences between individuals and disease states. Intriguingly, modulating the mechanical stiffness of materials used to activate T cells can rescue subsequent expansion. However, the magnitude of this effect and the optimal stiffnesses differ between individuals, complicating the use of mechanosensing to improve cell production. The ability to predict this long-term, substrate-dependent expansion from a short-term assay would accelerate the deployment of immunotherapy. Here, it is demonstrated that short-term cell spreading predicts subsequent, mechanosensitive expansion. As an initial task, cell spreading is used to identify whether a sample of cells came from a healthy donor or a Chronic Lymphocytic Leukemia (CLL) patient. Notably, a deep learning (DL) model outperforms morphometric approaches to this classification task. This system also successfully predicts the long-term expansion potential of cells as a function of both source and mechanical stiffness of the activating substrate. By predicting long-term T cell function from small, diagnostic samples, this approach will improve the reliability and efficacy of cell production and immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.